anti-Nipah

anti-Nipah browse page allows user to take a glance of the particular anti-Nipah ihibitor.By clicking on the table header arrows, user can sort entries in ascending or descending order.Moreover, the user can get the detal of every inhibitor by clicking on individual ID.

Total number of Records for Culture are 301

anti-Nipah_ID	Drug Name	Nipah virus strain	Assay	Activity Type	Activity	References
anti-Nipah_001	Ac-VALDPIDISIVLNKlKSDLEESKEWIRRSNKlLDSl-GSGSG-dPEG4-C-(CH2CON H2)-NH2	Nipah virus UMMC1	beta-galactosidase complementation assay	Inhibitory concentration	50 %	29566184
anti-Nipah_002	Ac-VALDPIDISIVLNKIKSDLEESKEWIRRSNKILDSl-GSGSG-dPEGa-C-Chol-NH2	Nipah virus UMMC1	beta-galactosidase complementation assay	Inhibitory concentration	50 %	29566184
anti-Nipah_003	Ac-VALDPI DISIVLN Kl KSDLEESKEWIRRSNKILDSI-GSGSGdPEG4-C-TOCO-NH2	Nipah virus UMMC1	beta-galactosidase complementation assay	Inhibitory concentration	50 %	29566184
anti-Nipah_004	Ac-VALDPIDISIVLNKIKSDLEESKEWIRRSNKILDSl-GSGSG-dPEG4-C-(PEG4-Cho\|)2-NH2	Nipah virus UMMC1	beta-galactosidase complementation assay	Inhibitory concentration	50 %	29566184
anti-Nipah_005	Ac-VALDPIDISIVLNKIKSDLEESKEWIRRSNKILDSl-GSGSG-dPEG4-C-(PEG4-Toco)2-NH2	Nipah virus UMMC1	beta-galactosidase complementation assay	Inhibitory concentration	50 %	29566184
anti-Nipah_008	N-[4-(1H-Tetrazol-1-yl)phenyl]-3,4-dihydro-2-naphthalenesulfonamide	Nipah virus Malaysia-1999	Iluminescence	Effective concentration	50 %	24735442
anti-Nipah_009	3,4-Difluoro-N-[4-(1H-tetrazol-1-yl)phenyl]benzenesulfonamide	Nipah virus Malaysia-1999	Iluminescence	Effective concentration	50 %	24735442
anti-Nipah_010	N,N-Dimethyl-1-(2-thienylsulfonyl)-5-indolinesulfonamide	Nipah virus Malaysia-1999	Iluminescence	Effective concentration	50 %	24735442
anti-Nipah_011	N,N-Dimethyl-1-(2-thienylsulfonyl)-5-indolinesulfonamide	Nipah virus Malaysia-1999	TCID50	TCID50	100 TCID50/ml	24735442
anti-Nipah_012	N-[4-(1H-Tetrazol-1-yl)phenyl]-3,4-dihydro-2-naphthalenesulfonamide	Nipah virus Malaysia-1999	TCID50	TCID50	10 TCID50/ml	24735442
anti-Nipah_013	3,4-Difluoro-N-[4-(1H-tetrazol-1-yl)phenyl]benzenesulfonamide	Nipah virus Malaysia-1999	TCID50	TCID50	<1O TCID50/ml	24735442
anti-Nipah_014	6-azauridine acetate	Nipah virus LUC2AM-Renilla Luciferase	Renilla luciferase	Effective concentration	50 %	24680955
anti-Nipah_015	6-azauridine acetate	Nipah virus Malaysia-1999	TCID50	Effective concentration	50 %	24680955
anti-Nipah_016	Pyrazofurin	Nipah virus LUC2AM-Renilla Luciferase	Renilla luciferase	Effective concentration	50 %	24680955
anti-Nipah_017	{2,2,2-trifluoro-N-[3-(N-naphthylcarbamoyl)(4,5,6,7-tetrahydrobenzo [beta]thiophen-2-yl)]acetamide	Nipah virus LUC2AM-Renilla Luciferase	Renilla luciferase	Effective concentration	50 %	24680955
anti-Nipah_018	{2,2,2-trifluoro-N-[3-(N-naphthylcarbamoyl)(4,5,6,7-tetrahydrobenzo [beta]thiophen-2-yl)]acetamide	Nipah virus Malaysia-1999	TCID50	Effective concentration	50 %	24680955
anti-Nipah_019	N-(1,3-benzodioxol-5-ylmethyl)-2-(3-cyano-2-methyl-1H-indol-1-yl)acetamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	39.55 %	24501399
anti-Nipah_020	N-benzyl-6-phenyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine hydrochloride	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	102.26 %	24501399
anti-Nipah_021	9H-carbazol-3-amine	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	55.68 %	24501399
anti-Nipah_022	7-(1H-benzimidazol-2-ylthio)-8-methyl[1,3]dioxolo[4,5-g]quinolin-6(5H)-one	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	63.7 %	24501399
anti-Nipah_023	N-[2-(2-methoxyethyl)-1,2,3,4-tetrahydropyrazino[1,2-a]benzimidazol-8-yl]benzamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	16 %	24501399
anti-Nipah_024	tris[4-(dimethylamino)phenyl]methanol	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	121.65 %	24501399
anti-Nipah_025	6-chloro-N-[3-(4-methyl-1H-pyrazol-1-yl)propyl]-2-(3-pyridinyl)-4-quinolinecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	94.08 %	24501399
anti-Nipah_026	1-(2-furoyl)-5-(2-furyl)-3-(3-methoxyphenyl)-4,5-dihydro-1H-pyrazole	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	5.15 %	24501399
anti-Nipah_027	2-[(1H-benzimidazol-2-ylmethyl)thio]-1-[2-(4-methylphenoxy)ethyl]-1H-benzimidazole	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	23.57 %	24501399
anti-Nipah_028	N-(3-chloro-4-fluorophenyl)-N-[4-(4-morpholinylsulfonyl)phenyl]urea	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	53.73 %	24501399
anti-Nipah_029	4-{[(5-methyl-2-thienyl)methyl]amino}phenol	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	15.92 %	24501399
anti-Nipah_030	N-[5-(1H-benzimidazol-2-yl)-2-methylphenyl]-1,3-benzodioxole-5-carboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	51.07 %	24501399
anti-Nipah_031	N-[1-benzyl-2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]benzamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	16.58 %	24501399
anti-Nipah_032	2-methoxy-N-[1-methyl-2-(1-pyrrolidinylmethyl)-1H-benzimidazol-5-yl]benzamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	6.45 %	24501399
anti-Nipah_033	N-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)-2-(2-naphthyloxy)acetamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	80.96 %	24501399
anti-Nipah_034	N-(2,5-dimethoxyphenyl)-N-[4-(trifluoromethyl)phenyl]urea	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	40.8 %	24501399
anti-Nipah_035	4-{[(1H-benzimidazol-2-ylthio)acetyl]amino}phenyl thiocyanate	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	31.81 %	24501399
anti-Nipah_036	N-(3,4-dichlorophenyl)-N-[3-(trifluoromethyl)phenyl]urea	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	44.08 %	24501399
anti-Nipah_037	N-1,3-benzodioxol-5-yl-6-chloro-2-(3-pyridinyl)-4-quinolinecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	55.7 %	24501399
anti-Nipah_038	N-(3-chlorophenyl)-N-(4-cyanophenyl)urea	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	63.91 %	24501399
anti-Nipah_039	N-[4-(1H-benzimidazol-2-yl)phenyl]-2-chloro-5-(4H-1,2,4-triazol-4-yl)benzamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	27.96 %	24501399
anti-Nipah_040	N-[3-(aminocarbonyl)-5-benzyl-2-thienyl]-2-methyl-3-furamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	18.33 %	24501399
anti-Nipah_041	4,5-dimethyl-2-{[(5-propyl-3-thienyl)carbonyl]amino}-N-(3-pyridinylmethyl)-3-thiophenecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	12.33 %	24501399
anti-Nipah_042	1-(isopropylamino)-3-(3-phenyl-4,5-dihydropyrazolo[4,3-a]carbazol-10(3H)-yl)-2-propanol	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	49.78 %	24501399
anti-Nipah_043	2-[(4-tert-butyl-1,3-thiazol-2-yl)amino]-8-quinolinol	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	2.06 %	24501399
anti-Nipah_044	N-(aminocarbonyl)-2-{[(5-methyl-3-thienyl)carbonyl]amino}-3-thiophenecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	46.11 %	24501399
anti-Nipah_045	2-chloro-N-(4-phenyl-1,3-thiazol-2-yl)-5-(4H-1,2,4-triazol-4-yl)benzamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	81.01 %	24501399
anti-Nipah_046	N-[3-(2-oxo-2H-chromen-3-yl)phenyl]-1,3-benzodioxole-5-carboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	58.07 %	24501399
anti-Nipah_047	4,5-dimethyl-2-[(phenoxyacetyl)amino]-N-(3-pyridinylmethyl)-3-thiophenecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	55.23 %	24501399
anti-Nipah_048	N-(4-{[(5-methyl-3-isoxazolyl)amino]sulfonyl}phenyl)-1-benzothiophene-3-carboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	45.06 %	24501399
anti-Nipah_049	3-[(1H-benzimidazol-2-ylmethyl)thio]-9-benzyl-9H-[1,2,4]triazolo[4,3-a]benzimidazole	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	12.87 %	24501399
anti-Nipah_050	methyl N-[4,6-bis(isopropylamino)-1,3,5-triazin-2-yl]-N-cyanoglycinate	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	88.36 %	24501399
anti-Nipah_051	N-(3,4-dichlorophenyl)-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	57.76 %	24501399
anti-Nipah_052	N-(3-pyridinylmethyl)dibenzo[b,d]furan-3-amine	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	31.98 %	24501399
anti-Nipah_053	(1,3-benzodioxol-5-ylmethyl)[4-(1-pyrrolidinyl)phenyl]amine	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	-8.16 %	24501399
anti-Nipah_054	4-methyl-5-phenyl-N-3-pyridinyl-2-thiophenecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	49.25 %	24501399
anti-Nipah_055	N-(2,5-dimethoxyphenyl)-2-(2-oxo-1,3-benzoxazol-3(2H)-yl)acetamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	30.96 %	24501399
anti-Nipah_056	3-[(2,4-dichlorophenoxy)methyl]-N-(3-pyridinylmethyl)benzamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	39.35 %	24501399
anti-Nipah_057	5-phenyl-2-(2-phenylethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	30.39 %	24501399
anti-Nipah_058	6-bromo-2-oxo-N-3-pyridinyl-2H-chromene-3-carboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	97.85 %	24501399
anti-Nipah_059	2-[(2-methyl-8-quinolinyl)amino]-4H-pyrido[3,2-e][1,3]thiazin-4-one	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	9.77 %	24501399
anti-Nipah_060	N-(3-chloro-4-fluorophenyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]urea	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	42.76 %	24501399
anti-Nipah_061	4-({[(3-chloro-4-fluorophenyl)amino]carbonyl}amino)-N-methylbenzenesulfonamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	41.82 %	24501399
anti-Nipah_062	2-(4-fluorophenyl)-N-(4-{[(4-methylphenyl)amino]sulfonyl}phenyl)acetamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	27.2 %	24501399
anti-Nipah_063	5-methyl-N-[4-(1-pyrrolidinylsulfonyl)phenyl]-3-thiophenecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	-11.7 %	24501399
anti-Nipah_064	2-amino-N-(3-chlorophenyl)-3-quinolinecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	46.45 %	24501399
anti-Nipah_065	2-(1,3-benzodioxol-5-yl)-1-(1,3-benzodioxol-5-ylmethyl)-1H-benzimidazole	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	13.74 %	24501399
anti-Nipah_066	N-{3-[(benzylamino)carbonyl]phenyl}-5-methyl-3-thiophenecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	15.09 %	24501399
anti-Nipah_067	8-chloro-N-[3-(3-methyl-1H-pyrazol-1-yl)propyl]-2-(2-pyridinyl)-4-quinolinecarboxamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	-0.5 %	24501399
anti-Nipah_068	N-[4-(2,4-difluorophenyl)-1,3-thiazol-2-yl]-2-(2-thienyl)acetamide	Nipah virus Peptide -F0, amino acids 105 to 114	CatL-Peptide cleavage	Percentage inhibition	12.4 %	24501399
anti-Nipah_069	Brilliant Green	Nipah virus Malaysia-1999	Immnuolabelling assay	Inhibitory concentration	50 %	19889218
anti-Nipah_070	Gentian Violet	Nipah virus Malaysia-1999	Immnuolabelling assay	Inhibitory concentration	50 %	19889218
anti-Nipah_071	Gliotoxin	Nipah virus Malaysia-1999	Immnuolabelling assay	Inhibitory concentration	50 %	19889218
anti-Nipah_072	Brilliant Green	Nipah virus Malaysia-1999	TCID50	Viral titer	>100 TCID50/ml	19889218
anti-Nipah_073	Gentian Violet	Nipah virus Malaysia-1999	TCID50	Viral titer	>100 TCID50/ml	19889218
anti-Nipah_074	Gliotoxin	Nipah virus Malaysia-1999	TCID50	Viral titer	>100 TCID50/ml	19889218
anti-Nipah_075	Brilliant Green	Nipah virus Pseudotyped_pNiV	Immunofluorescence	Inhibitory concentration	50 %	19889218
anti-Nipah_076	Gentian Violet	Nipah virus Pseudotyped_pNiV	Immunofluorescence	Inhibitory concentration	50 %	19889218
anti-Nipah_077	Gliotoxin	Nipah virus Pseudotyped_pNiV	Immunofluorescence	Inhibitory concentration	50 %	19889218
anti-Nipah_078	2-benzyl-1,3-benzoxazol-5-amine	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_079	N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_080	N-(3-chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_081	7-(4-carbamoylpiperidin-1-yl)-1-cyclopropyl-N-[(2,4-dichlorophenyl)methyl]-6-fluoro-4-oxo-1,2,3,4-tetrahydroquinoline-3-carboxamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_082	N-[(2,4-dichlorophenyl)methyl]-6-fluoro-1-(2-hydroxyethyl)-7-[4-(oxirane-2-carbonyl)piperidin-1-yl]-4-oxo-1,2,3,4-tetrahydroquinoline-3-carboxamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_083	4-oxo-1,4-dihydroquinoline-3,6-dicarboxylic acid	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_084	N-[(2,4-dichlorophenyl)methyl]-6-fluoro-1-(2-hydroxyethyl)-7-[4-(oxirane-2-carbonyl)piperazin-1-yl]-4-oxo-1,2,3,4-tetrahydroquinoline-3-carboxamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_085	1-cyclopropyl-N-[(2,4-dichlorophenyl)methyl]-6-fluoro-7-[4-(oxirane-2-carbonyl)piperazin-1-yl]-4-oxo-1,2,3,4-tetrahydroquinoline-3-carboxamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_086	3,5-diethyl 4-hydroxy-2,6-bis(4-nitrophenyl)-1-(prop-2-en-1-yl)-1,2,3,6-tetrahydropyridine-3,5-dicarboxylate	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Effective concentration	50 %	19499921
anti-Nipah_087	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_088	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_089	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_090	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_091	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_092	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_093	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_094	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_095	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_096	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_097	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_098	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_099	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_100	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_101	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_102	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_103	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_104	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_105	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_106	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_107	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_108	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_109	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_110	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_111	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_112	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_113	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_114	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_115	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_116	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_117	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_118	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_119	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_120	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_121	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_122	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_123	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_124	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_125	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_126	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_127	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_128	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_129	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_130	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_131	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_132	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_133	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_134	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_135	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_136	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_137	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_138	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_139	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_140	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_141	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_142	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_143	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_144	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_145	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_146	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_147	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_148	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_149	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_150	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_151	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_152	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_153	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_154	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_155	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_156	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_157	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_158	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_159	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_160	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_161	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_162	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_163	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_164	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_165	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_166	AAHL 7	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_167	AAHL 13	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_168	AAHL 15	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_169	AAHL 16	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_170	AAHL 18	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_171	AAHL 22	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_172	AAHL 23	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_173	AAHL 33	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_174	AAHL 42	Nipah virus Malaysia-1999	Chemiluminescent	Inhibitory concentration	50 %	19428741
anti-Nipah_175	4-amino-1-[5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Rec. M-GFP2AM	Fluorescence	Effective concentration	50 %	29601894
anti-Nipah_176	4-Amino-1-[(2R,4R,5R)-5-azido-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Rec. M-GFP2AM	Fluorescence	Effective concentration	50 %	29601894
anti-Nipah_177	4-Amino-1-[(2R,3R,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Rec. M-GFP2AM	Fluorescence	Effective concentration	50 %	29601894
anti-Nipah_178	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Rec. M-GFP2AM	Cytopathic effect assay	Effective concentration	50 %	29601894
anti-Nipah_179	4-Amino-1-[(2R,4R,5R)-5-azido-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Rec. M-GFP2AM	Cytopathic effect assay	Effective concentration	50 %	29601894
anti-Nipah_180	4-Amino-1-[(2R,3R,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Rec. M-GFP2AM	Cytopathic effect assay	Effective concentration	50 %	29601894
anti-Nipah_181	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Malaysia-1999	Cytopathic effect assay	Effective concentration	50 %	29601894
anti-Nipah_182	4-Amino-1-[(2R,4R,5R)-5-azido-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Malaysia-1999	Cytopathic effect assay	Effective concentration	50 %	29601894
anti-Nipah_183	4-Amino-1-[(2R,3R,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Malaysia-1999	Cytopathic effect assay	Effective concentration	50 %	29601894
anti-Nipah_184	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Malaysia-1999	TCID50	Effective concentration	50 %	29601894
anti-Nipah_185	4-Amino-1-[(2R,4R,5R)-5-azido-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Malaysia-1999	TCID50	Effective concentration	50 %	29601894
anti-Nipah_186	4-Amino-1-[(2R,3R,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone	Nipah virus Malaysia-1999	TCID50	Effective concentration	50 %	29601894
anti-Nipah_187	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus NiV-Luc2AM	Luciferase assay	Effective concentration	50 %	28629988
anti-Nipah_188	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus NiV-Luc2AM	Luciferase assay	Effective concentration	50 %	28629988
anti-Nipah_189	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Malaysia	Cytopathic effect assay	Effective concentration	50 %	28629988
anti-Nipah_190	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Malaysia	Cytopathic effect assay	Effective concentration	50 %	28629988
anti-Nipah_191	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Malaysia	TCID50	Effective concentration	50 %	28629988
anti-Nipah_192	4-amino-1-[(2R,3R,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one	Nipah virus Malaysia	TCID50	Effective concentration	50 %	28629988
anti-Nipah_193	2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide	Nipah virus NiV-Luc	Luciferase assay	Effective concentration	50 %	25986249
anti-Nipah_194	2-diphenylboranyloxyethanamine	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_195	5-(methylamino)-2-[[(2S,3R,5R,8S,9S)-3,5,9-trimethyl-2-[1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_196	2,5-ditert-butylbenzene-1,4-diol	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_197	ethyl 12-[[2-[(2R,3R)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_198	Dantrolene	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_199	Ionomycin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_200	Ryanodine	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_201	Thapsigargin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_202	Xestospongin C	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_203	Agatoxin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_204	Amlodipine besylate	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_205	Conotoxin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_206	Gabapentin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_207	Lanthanum chloride	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_208	Mibefradil	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_209	Nifedipine	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_210	Praziquantel	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_211	Tetrandine	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_212	Verapamil	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_213	5-N-ethyl isopropyl amiloride	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_214	Amiloride	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_215	Benzamil	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_216	Monensin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_217	Phenytoin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_218	7-octyl-indolactam	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_219	Cyclosporine	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_220	Gliotoxin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_221	Oleic Acid	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_222	Phenoxybenzamine	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_223	PKC Inhibitor	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_224	PMA	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_225	Rottlerin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_226	U73122	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_227	25-hydroxy-cholecalciferol	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_228	4-hydroxy-tamoxifen	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_229	Argo-vasopressin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_230	Bradykinin	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_231	Caffeine	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_232	Cholecalciferol	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_233	Clotrimazole	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_234	Propranolol	Nipah virus Malaysia-1999	Immunolabeling assay	Inhibitory concentration	50 %	20668647
anti-Nipah_235	Chloroquine	Nipah virus Malaysia	Plaque assay	Inhibitory concentration	50 %	19889926
anti-Nipah_236	Ribavirin	Nipah virus Malaysia	Plaque assay	Inhibitory concentration	50 %	19889926
anti-Nipah_239	Chloroquine	Nipah virus NA	Chemiluminescent	Inhibitory concentration	50 %	19264786
anti-Nipah_240	Favipiravir	Nipah virus Malaysia	Plaque assay	Effective concentration	50 %	29765101
anti-Nipah_241	Favipiravir	Nipah virus Bangladesh	Plaque assay	Effective concentration	50 %	29765101
anti-Nipah_242	Favipiravir	Nipah virus rNiV-Gluc-eGFP	Plaque assay	Effective concentration	50 %	29765101
anti-Nipah_243	Favipiravir	Nipah virus rNiV-Gluc-eGFP	Cytopathic effect assay	Virus titer	4 log(PFU/ml)	29765101
anti-Nipah_244	Favipiravir	Nipah virus rNiV-Gluc-eGFP	Real time PCR	Virus titer	10 fold	29765101
anti-Nipah_251	(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile	Nipah virus Rec. M-Luc2AM	Renilla luciferase	Effective concentration	50 %	28262699
anti-Nipah_252	(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile	Nipah virus Malaysia	TCID50	Effective concentration	50 %	28262699
anti-Nipah_253	(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile	Nipah virus Bangladesh-2004	TCID50	Effective concentration	50 %	28262699
anti-Nipah_254	(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile	Nipah virus Bangladesh-2004	Cytopathic effect assay	Percentage inhibition	90 %	28262699
anti-Nipah_255	(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile	Nipah virus Malaysia	Cytopathic effect assay	Percentage inhibition	90 %	28262699
anti-Nipah_256	2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate	Nipah virus Rec. M-Luc2AM	Renilla luciferase	Effective concentration	50 %	28262699
anti-Nipah_257	2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate	Nipah virus Malaysia	TCID50	Effective concentration	50 %	28262699
anti-Nipah_258	2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate	Nipah virus Bangladesh-2004	TCID50	Effective concentration	50 %	28262699
anti-Nipah_259	2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate	Nipah virus Bangladesh-2004	Cytopathic effect assay	Percentage inhibition	90 %	28262699
anti-Nipah_260	2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate	Nipah virus Malaysia	Cytopathic effect assay	Percentage inhibition	99 %	28262699
anti-Nipah_261	N-(3-cyanophenyl)-2-phenylacetamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Fusion Inhibition	0 %	20685931
anti-Nipah_262	3-[(2-phenylacetyl)amino]benzoic acid	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Fusion Inhibition	0 %	20685931
anti-Nipah_263	methyl 3-[(2-phenylacetyl)amino]benzoate	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Fusion Inhibition	35 %	20685931
anti-Nipah_264	5-nitro-2-(2-phenylacetamido)benzamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Fusion Inhibition	0 %	20685931
anti-Nipah_265	4-nitro-2-[(2-phenylacetyl)amino]benzamide	Nipah virus Nipah G/F fusion expression vector	Syncytia formation	Fusion Inhibition	10 %	20685931
anti-Nipah_266	Carbocyclic 3-deazaadenosine	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_267	(-)-5 Noraristeromycin	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_268	DHCaA	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_269	Ribavirin	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	NA NA	16641448
anti-Nipah_270	EICAR	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_271	Pyrazofurin	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_272	Carbodine	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_273	6-Aza-uridine	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_274	Poly(I)-poly(C12U)	Nipah virus Malaysia-1999	Cytopathic effect assay	Inhibitory concentration	100 %	16641448
anti-Nipah_277	(5Z)-5-[(5-phenylfuran-2-yl)methylidene]-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_278	(5Z)-3-Ethyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_279	(5Z)-5-[(5-Phenyl-2-furyl)methylene]-3-propyl-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_280	(5Z)-3-Benzyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_281	(5Z)-3-Methyl-5-[(5-phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_282	(5Z)-5-{[5-(3-Chlorophenyl)-2-furyl]methylene}-3-ethyl-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_283	(5Z)-3-Ethyl-5-{[5-(3-fluorophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_284	3-Ethyl-5-{[5-(2-fluorophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_285	(5Z)-5-{[5-(2-Chlorophenyl)-2-furyl]methylene}-3-ethyl-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_286	(5Z)-3-ethyl-5-{[5-(2-methoxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_287	(5Z)-3-ethyl-5-{[5-(3-methoxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_288	(5Z)-3-Ethyl-2-thioxo-5-({5-[2-(trifluoromethyl)phenyl]-2-furyl}methylene)-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_289	(5Z)-3-Ethyl-5-[(5-methyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_290	(5Z)-3-Ethyl-5-(2-furylmethylene)-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_291	(5Z)-3-Ethyl-5-{[5-(2-nitrophenyl)-2-furyl]methylene}-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_292	(5Z)-3-ethyl-5-{[5-(2-hydroxyphenyl)furan-2-yl]methylidene}-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_293	(5Z)-5-{[5-(2-aminophenyl)furan-2-yl]methylidene}-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_294	(5Z)-3-ethyl-5-[(5-phenylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_295	(5Z)-5-({[1,1-biphenyl]-3-yl}methylidene)-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_296	2-(5-{[(5Z)-3-ethyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}furan-2-yl)benzene-1-diazonium; tetrafluoroboranuide	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_297	3-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl acetate	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_298	(5Z)-3-(3-hydroxypropyl)-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_299	(5Z)-3-ethyl-5-[(2-phenyl-1,3-oxazol-5-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_300	3-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl 4-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}butanoate	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_301	(5Z)-5-[(5-Phenyl-2-furyl)methylene]-2-thioxo-3-vinyl-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_302	(5Z)-3-Ethyl-5-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazolidine-2,4-dione	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_303	(5Z)-3-ethenyl-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidine-2,4-dithione	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_304	(5Z)-3-ethyl-5-{[5-(2-nitrophenyl)furan-2-yl]methylidene}-1,3-thiazolidine-2,4-dithione	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_305	(5Z)-3-ethenyl-5-[(5-phenylfuran-2-yl)methylidene]-4-sulfanylidene-1,3-thiazolidin-2-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_306	(5Z)-3-ethyl-5-{[5-(2-nitrophenyl)furan-2-yl]methylidene}-4-sulfanylidene-1,3-thiazolidin-2-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_307	(5Z)-5-[(5-Phenyl-2-furyl)methylene]-2-thioxo-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_308	(5Z)-5-[(5-phenylfuran-2-yl)methylidene]-3-(prop-2-yn-1-yl)-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_309	5-[(5-phenylfuran-2-yl)methyl]-3-(prop-2-en-1-yl)-2-sulfanylidene-1,3-thiazolidin-4-one	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_310	N-{3-[(5Z)-2,4-dioxo-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidin-3-yl]propyl}acetamide	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_311	(5Z)-3-(3-aminopropyl)-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidine-2,4-dione	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_312	2-methylpropyl N-{3-[(5Z)-4-oxo-5-[(5-phenylfuran-2-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]propyl}carbamate	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A
anti-Nipah_313	3-[(5Z)-2,4-dioxo-5-[(5-phenylfuran-2-yl)methylidene]-1,3-thiazolidin-3-yl]propyl 4-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}butanoate	Nipah virus NiV-pVSV	Plaque assay	Inhibitory concentration	50 %	WO2010044924A